Synmosa Biopharma CorpTPEX: 4114

Board of Directors resolved to convene the 2022 Annual Shareholders' Meeting

· Issued by Synmosa Biopharma Corp
Close
Today's Information

Provided by: SYNMOSA BIOPHARMA CORPORATION
SEQ_NO 1 Date of announcement 2022/03/29 Time of announcement 15:27:53
Subject
 Synmosa Board of Directors resolved to convene the
2022 Annual Shareholders' Meeting
Date of events 2022/03/29 To which item it meets paragraph 17
Statement
1.Date of the board of directors resolution:2022/03/29
2.General shareholders' meeting date:2022/05/25
3.General shareholders' meeting location:4F., No. 207, Sec. 2, Tiding Blvd.,
Neihu Dist., Taipei City 114064, Taiwan (R.O.C.) (4A meeting room)
4.Shareholders meeting will be held by means of (physical shareholders
 meeting/ visual communication assisted shareholders meeting /
 visual communication shareholders meeting):
physical shareholders meeting
5.Cause for convening the meeting I.Reported matters:
(1)Report of the 2021 Business Report
(2)Report of the 2021 Audit Committee's Report
(3)Report of the distribution of the 2021 employees' and directors'
compensations
(4)Report of the 2021 earnings and capital reserve in cash dividends
distribution
(5)Report of the amendments to the company's"Management of
Operation of Board Meetings"
(6)Report of the amendment on the Company's "Codes of Sustainable
Development"
(7)Report of the sale of the Company's Sin-Gen Plant
6.Cause for convening the meeting II.Acknowledged matters:
(1)To approve the 2021 Business Report and Financial Statements
(2)To approve the proposal for the distribution of 2021 earnings
7.Cause for convening the meeting III.Matters for Discussion:
(1)To approve increase capital stock by earnings recapitalization
(2)To approve the amendments of the company's "Article of Incorporation"
(3)To approve the amendments of the company's "Procedure for Making
Endorsements and Guarantees"
(4)To approve the amendments of the company's "Procedure for Lending
Funds to Other Parties"
(5)To approve the amendments of the company's "Operational Procedures
for Financial Derivative Transaction"
(6)To approve the amendments of the company's "Rules Governing the
Election of Directors"
(7)To approve the abolishment and to re-established the company's
"Rules of Procedures for Shareholders' Meetings"
8.Cause for convening the meeting IV.Election matters:
To elect Directors (including three Independent Directors)
9.Cause for convening the meeting V.Other Proposals:
To approve the removal of non-competition restrictions on the
company's new Directors (including Independent Directors) and
their representatives elected in the shareholders' meeting
10.Cause for convening the meeting VI.Extemporary Motions:none
11.Book closure starting date:2022/03/27
12.Book closure ending date:2022/05/25
13.Any other matters that need to be specified:none